Cryoprobe Versus Forceps for Transbronchial Biopsy (NCT05751278) | Clinical Trial Compass
CompletedNot Applicable
Cryoprobe Versus Forceps for Transbronchial Biopsy
United States500 participantsStarted 2023-02-27
Plain-language summary
The purpose of this study is to compare the effectiveness of transbronchial biopsy done by a 1.1mm cryoprobe versus the standard 2.0mm forceps.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or Female, ≥ 18-years-old
* Scheduled to undergo bronchoscopy with transbronchial biopsy per standard of care
Exclusion Criteria:
* Pregnant or nursing woman or woman of child-bearing potential who refuse to take a pregnancy test prior to enrollment
* Severe pulmonary hypertension (RVSP \> 60 mmHg)
* Stroke within the last 6 months or myocardial infarction within the last 3 months
* Presence of bleeding disorder
* Platelet count \< 50,000 per mL at time of enrollment
* Use of systemic anticoagulation or antiplatelet therapy without the ability to hold therapy for the recommended time prior to invasive procedure (aspirin monotherapy is acceptable)
* Do Not Resuscitate (DNR) status
* Do Not Intubate (DNI) status
What they're measuring
1
Diagnostic yield as assessed by number of patients for which the procedure led to a diagnosis